13种主要精神疾病的转录组范围结构方程模型:跨疾病风险与药物重定位
该基因组学研究应用转录组范围结构方程模型(T-SEM),分析13种主要精神疾病共享风险的5个基因组因子相关的基因表达模式。T-SEM识别出466个与基因组因子显著相关的基因(z ≥ 5.02)和36个具有疾病特异效应的基因,多数关联基因对应思维障碍因子(由双相障碍和精神分裂症定义)。研究还识别出可重定位以靶向这些基因的现有药物干预。
要点
- T-SEM识别466个与基因组因子显著相关的基因(z ≥ 5.02)和36个疾病特异效应基因。
- 多数关联基因对应思维障碍因子(双相障碍和精神分裂症定义)。
- 识别出可重定位靶向思维障碍因子或跨诊断p因子相关基因的现有药物。
核心结论
- T-SEM揭示了与精神疾病遗传重叠和独特性相关的基因表达模式。
- 研究识别出可重定位以靶向跨疾病风险相关基因的现有药物干预。
研究设计与样本
- 基因组学研究应用多变量转录组方法T-SEM,分析13种主要精神疾病共享风险的5个基因组因子。
- 数据收集自数据库建立至2023年2月20日。
- 使用Broad Institute Connectivity Map药物重定位数据库和Drug-Gene Interaction Database识别靶向相关基因的药物。
主要发现
- T-SEM识别出466个基因表达与基因组因子显著相关(z ≥ 5.02)。
- 识别出36个具有疾病特异效应的基因。
- 多数关联基因对应由双相障碍和精神分裂症定义的思维障碍因子。
关键数值与推荐
- 基因表达与基因组因子显著相关的阈值:z ≥ 5.02。
临床怎么用
- 研究结果可为跨诊断精神疾病共病提供药物重定位线索。
- 未来多变量药物重定位框架有望识别针对共病精神表现的新药理干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Psychiatric disorders display high levels of comorbidity and genetic overlap, necessitating multivariate approaches for parsing convergent and divergent psychiatric risk pathways. Identifying gene expression patterns underlying cross-disorder risk also stands to propel drug discovery and repurposing in the face of rising levels of polypharmacy. OBJECTIVE: To identify gene expression patterns underlying genetic convergence and divergence across psychiatric disorders along with existing pharmacological interventions that target these genes. DESIGN, SETTING, AND PARTICIPANTS: This genomic study applied a multivariate transcriptomic method, transcriptome-wide structural equation modeling (T-SEM), to investigate gene expression patterns associated with 5 genomic factors indexing shared risk across 13 major psychiatric disorders. Follow-up tests, including overlap with gene sets for other outcomes and phenome-wide association studies, were conducted to better characterize T-SEM results. The Broad Institute Connectivity Map Drug Repurposing Database and Drug-Gene Interaction Database public databases of drug-gene pairs were used to identify drugs that could be repurposed to target genes found to be associated with cross-disorder risk. Data were collected from database inception up to February 20, 2023. MAIN OUTCOMES AND MEASURES: Gene expression patterns associated with genomic factors or disorder-specific risk and existing drugs that target these genes. RESULTS: In total, T-SEM identified 466 genes whose expression was significantly associated (z ≥ 5.02) with genomic factors and 36 genes with disorder-specific effects. Most associated genes were found for a thought disorders factor, defined by bipolar disorder and schizophrenia. Several existing pharmacological interventions were identified that could be repurposed to target genes whose expression was associated with the thought disorders factor or a transdiagnostic p factor defined by all 13 disorders. CONCLUSIONS AND RELEVANCE: The findings from this study shed light on patterns of gene expression associated with genetic overlap and uniqueness across psychiatric disorders. Future versions of the multivariate drug repurposing framework outlined here have the potential to identify novel pharmacological interventions for increasingly common, comorbid psychiatric presentations.
引用
- Grotzinger AD, Singh K, Miller-Fleming TW, et al. Transcriptome-Wide Structural Equation Modeling of 13 Major Psychiatric Disorders for Cross-Disorder Risk and Drug Repurposing. JAMA Psychiatry. 2023. PMID: 37314780. doi:10.1001/jamapsychiatry.2023.1808
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。